US FDA clears Nexxt Spine’s Nexxt Matrixx system

108

Nexxt Spine Nexxt MatrixThe US Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Nexxt Spine for its Nexxt Matrixx system.

The devices leverage “Nexxt generation” technology to create interbody and vertebral body replacement devices with optimised open architectural porosity, residue-free surface technology, and robust radiographic imaging performance.

Nexxt Spine uses 3D-printed porous titanium to create interbody and vertebral body replacement devices. The technology is designed to offer open architectural porosity, residue-free surface technology, and robust radiographic imaging performance.

The devices exhibit up to four times more surface area for bone apposition and up to twice more open pore volume than conventional implants.

The first Next Matrixx products are available in both interbody and vertebral body replacement options. They are available in an assortment of height, length, width and lordotic angulation combinations.

Earlier this year, the company released the Inertia Corti-Fixx cortical-cancellous pedicle screw system. In 2015, Nexxt Spine launched the DT Elite guide system and the Struxxture anterior cervical plating system.

Andy Elsbury, president of Nexxt Spine, states, “We will continue to expand our Nexxt Matrixx offering throughout 2017 and into 2018 to ensure this differentiated technology is available for all spinal fusion surgical approaches.”

LEAVE A REPLY